Drug Testing Market Size, Share & Trends Analysis Report 2021 - 2028
Drug Testing Industry Overview
The global drug testing market size is expected to reach USD 11.7 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.9% from 2021 to 2028. The introduction of innovative tests, stringent regulation mandating drug testing, and growing substance abuse & addiction are some of the factors anticipated to foster market growth during the forecast period.
Drug abuse and addiction is a global problem, affecting millions of people. As per the World Drug Report published by UNODC, in 2019, around 35.0 million people were suffering from drug use disorders globally. Such a high rate of drug abuse and substance use disorders has created a major demand for innovative tests to prevent, treat, and manage such cases. Several key players operating in this space are introducing innovative and efficient products to meet this growing demand.
For instance, in June 2019, Quidel Corporation received the U.S. FDA’s 510(k) clearance to market its fluorescence immunoassay—Quidel Triage TOX Drug Screen, 94600. This is intended for detecting the presence of metabolites or drugs in urine. Moreover, in June 2020, Cordant Health Solutions offered video-observed oral fluid drug testing to help courts & government agencies to monitor participants during the COVID-19 pandemic. This aided in combating several challenges faced by people with substance abuse disorders during the pandemic.
Continuous government initiatives and implementation of strict substance abuse testing regulations to ensure safety have derived the demand for its testing products. In July 2020, the New Zealand government introduced a new bill that provides police the power to conduct random roadside drug testing of drivers to reduce impaired driving in the country. The new bill allows usage of oral fluid tests to check drivers for substances such as cocaine, ecstasy, cannabis, opiates, methamphetamine, and benzodiazepines. Also, in February 2020, the Directorate General of Civil Aviation in India introduced extensive tests for pilots and flight crew members for psychoactive substances such as opioids & cannabis to ensure safe air travel.
Drug Testing Market Segmentation
Grand View Research has segmented the global drug testing market on the basis of product type, sample type, drug type, end use, and region:
Based on the Product Type Insights, the market is segmented into Consumables, Instruments, Rapid Testing Devices, and Services.
- The consumables segment dominated the market in 2020 with a revenue share of 34.3%. The increasing launch of advanced consumables that provide improved solutions to make testing easy, accurate, and fast have accelerated the market growth.
- The services segment accounted for the second-largest revenue share in 2020. An increase in strategic initiatives being undertaken by various companies such as acquisitions, collaborations, and partnerships to support public safety and government agencies, has propelled the segmental growth.
Based on the Sample Type Insights, the market is segmented into Urine Samples, Oral Fluid Samples, Hair Samples, and Other Samples.
- The urine samples segment dominated the market and accounted for the largest revenue share of 40.8% in 2020. The segment is projected to grow at the fastest rate during the forecast period. This high growth can be attributed to the fact that urine samples are the most commonly used sample type to detect the presence of illicit substances.
- The oral fluid sample segment accounted for the significant market share as it is a quicker and less invasive sample to collect at the roadside. According to NCBI 2020 study, a survey conducted among staff as well as patients concluded that oral fluid samples are preferred over urine samples as they help save time and maintain dignity, regardless of the extra costs.
Based on the Drug Type Insights, the market is segmented into Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD, and Others.
- The cannabis/marijuana segment dominated the drug testing market and accounted for the largest revenue share of 25.9% in 2020. This can be attributed to the fact that marijuana or cannabis is the most commonly used illicit substance in key markets, thus creating a high demand for its testing kits and instruments.
- The Opioids segment held the second-largest revenue share in 2020. This high share can be attributed to increased opioid crises in key markets including North America and the introduction of innovative opioid testing solutions.
Based on the End-use Insights, the market is segmented into Drug Testing Laboratories, Workplaces, Hospitals, and Others.
- Drug testing laboratories dominated the market and held the largest revenue share of 36.0% in 2020. This high share can be attributed to their wide acceptance due to their accurate results. Drug testing laboratories can test for the presence of any illicit substance, which is not possible with rapid tests.
- Workplaces are projected to be the fastest-growing segment over the forecast period owing to the rising use of substance abuse screening in pre-employment as well as random drug tests to ensure drug-free premises. Moreover, in case of workplace accidents, drug tests can be used to check if the accident happened under influence of drugs, thus removing the responsibility of the employer for damages.
Drug Testing Regional Outlook
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa (MEA)
Key Companies Profile & Market Share Insights
Key companies are engaged in different growth strategies such as new product development, mergers and acquisitions, and geographical expansion to capture larger shares in the market. For instance, in April 2019, Thermo Fisher Scientific launched CEDIA Mitragynine (Kratom) Assay for criminal justice and forensic use. Some of the prominent players in the global drug testing market include:
- Quest Diagnostics Incorporated
- Abbott Laboratories
- Quidel Corporation
- Hoffmann-La Roche
- Thermo Fisher Scientific, Inc.
- Siemens Healthineers
- Bio-Rad Laboratories, Inc.
- Agilent Technologies, Inc.
- LabCorp
- Drägerwerk AG & CO. KGaA
- Clinical Reference Laboratory (CRL), Inc.
- Cordant Health Solutions
- Legacy Medical Services, LLC
- Omega Laboratories, Inc.
Order a free sample PDF of the Drug Testing Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Comments
Post a Comment